CL2013001882A1 - Procedimiento de sintesis industrial del compuesto de formula (i) agomelatina, a partir de cianuro de alilo; compuestos intermediarios. - Google Patents

Procedimiento de sintesis industrial del compuesto de formula (i) agomelatina, a partir de cianuro de alilo; compuestos intermediarios.

Info

Publication number
CL2013001882A1
CL2013001882A1 CL2013001882A CL2013001882A CL2013001882A1 CL 2013001882 A1 CL2013001882 A1 CL 2013001882A1 CL 2013001882 A CL2013001882 A CL 2013001882A CL 2013001882 A CL2013001882 A CL 2013001882A CL 2013001882 A1 CL2013001882 A1 CL 2013001882A1
Authority
CL
Chile
Prior art keywords
agomelatine
compound
formula
synthesis process
industrial synthesis
Prior art date
Application number
CL2013001882A
Other languages
English (en)
Inventor
Samir Zard
Béatrice Sire
Mehdi Boumediene
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44088993&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2013001882(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of CL2013001882A1 publication Critical patent/CL2013001882A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/06Preparation of carboxylic acid amides from nitriles by transformation of cyano groups into carboxamide groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/02Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/37Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by etherified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/40Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by doubly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hospice & Palliative Care (AREA)
  • Reproductive Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CL2013001882A 2011-01-05 2013-06-25 Procedimiento de sintesis industrial del compuesto de formula (i) agomelatina, a partir de cianuro de alilo; compuestos intermediarios. CL2013001882A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1100024A FR2970000B1 (fr) 2011-01-05 2011-01-05 Nouveau procede de synthese de l'agomelatine

Publications (1)

Publication Number Publication Date
CL2013001882A1 true CL2013001882A1 (es) 2013-12-06

Family

ID=44088993

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2013001882A CL2013001882A1 (es) 2011-01-05 2013-06-25 Procedimiento de sintesis industrial del compuesto de formula (i) agomelatina, a partir de cianuro de alilo; compuestos intermediarios.

Country Status (43)

Country Link
US (2) USRE46218E1 (es)
EP (1) EP2661422B9 (es)
JP (1) JP5837616B2 (es)
KR (1) KR101543432B1 (es)
CN (1) CN103313965B (es)
AP (1) AP3609A (es)
AR (1) AR084780A1 (es)
AU (1) AU2012220474B2 (es)
BR (1) BR112013017307A2 (es)
CA (1) CA2823587C (es)
CL (1) CL2013001882A1 (es)
CO (1) CO6731101A2 (es)
CR (1) CR20130301A (es)
CU (1) CU24289B1 (es)
CY (1) CY1117774T1 (es)
DK (1) DK2661422T3 (es)
EA (1) EA022077B1 (es)
EC (1) ECSP13012735A (es)
ES (1) ES2583682T3 (es)
FR (1) FR2970000B1 (es)
GE (1) GEP20156365B (es)
HK (1) HK1189571A1 (es)
HR (1) HRP20160713T1 (es)
HU (1) HUE028471T2 (es)
IL (1) IL227281A (es)
JO (1) JO3200B1 (es)
ME (1) ME02408B (es)
MX (1) MX2013007837A (es)
MY (1) MY162977A (es)
NI (1) NI201300062A (es)
PE (1) PE20140037A1 (es)
PL (1) PL2661422T3 (es)
RS (1) RS54753B9 (es)
RU (1) RU2550812C2 (es)
SA (1) SA112330134B1 (es)
SG (1) SG191733A1 (es)
SI (1) SI2661422T1 (es)
TN (1) TN2013000274A1 (es)
TW (1) TWI438180B (es)
UA (1) UA104122C2 (es)
UY (1) UY33845A (es)
WO (1) WO2012113999A1 (es)
ZA (1) ZA201305027B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103058879B (zh) * 2012-12-20 2015-09-09 安徽悦康凯悦制药有限公司 阿戈美拉汀的制备方法
CN103804232B (zh) * 2014-01-26 2015-08-19 江西同和药业股份有限公司 一种1-氰基-1-(7-甲氧基-3,4-二氢-1-萘基)甲醇酯类化合物及其制备方法和应用
CN107353229B (zh) * 2017-08-08 2019-04-30 许昌恒生制药有限公司 一种阿戈美拉汀中间体的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine
FR2866334B1 (fr) 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese du (7-methoxy-1-naphtyl) acetonitrile et application a la synthese de l'agomelatine
CN101486665B (zh) 2009-03-03 2013-04-17 上海医药工业研究院 阿戈美拉汀中间体2-(7-甲氧基-1-萘基)乙酰胺的制备方法

Also Published As

Publication number Publication date
UA104122C2 (uk) 2013-12-25
CN103313965A (zh) 2013-09-18
RU2013136344A (ru) 2015-02-10
NI201300062A (es) 2013-12-11
NZ612173A (en) 2015-08-28
FR2970000B1 (fr) 2013-01-04
US20130289307A1 (en) 2013-10-31
CO6731101A2 (es) 2013-08-15
ES2583682T3 (es) 2016-09-21
US8853449B2 (en) 2014-10-07
AU2012220474B2 (en) 2015-08-20
BR112013017307A2 (pt) 2016-10-04
GEP20156365B (en) 2015-09-10
SI2661422T1 (sl) 2016-08-31
HK1189571A1 (en) 2014-06-13
CA2823587C (fr) 2015-11-24
ES2583682T9 (es) 2016-10-31
WO2012113999A8 (fr) 2013-08-01
USRE46218E1 (en) 2016-11-29
CA2823587A1 (fr) 2012-08-30
AU2012220474A1 (en) 2013-07-11
CN103313965B (zh) 2015-08-05
MY162977A (en) 2017-07-31
JO3200B1 (ar) 2018-03-08
EA022077B1 (ru) 2015-10-30
CU24289B1 (es) 2017-12-08
ME02408B (me) 2016-09-20
AP3609A (en) 2016-02-26
CR20130301A (es) 2013-08-08
EA201300794A1 (ru) 2014-02-28
EP2661422B9 (fr) 2016-09-07
IL227281A0 (en) 2013-09-30
AR084780A1 (es) 2013-06-26
DK2661422T3 (en) 2016-10-24
ZA201305027B (en) 2014-03-26
AP2013007022A0 (en) 2013-07-31
CU20130092A7 (es) 2013-08-29
SG191733A1 (en) 2013-08-30
JP2014509309A (ja) 2014-04-17
RS54753B1 (sr) 2016-10-31
EP2661422B1 (fr) 2016-04-20
EP2661422A1 (fr) 2013-11-13
PL2661422T3 (pl) 2016-10-31
PE20140037A1 (es) 2014-02-01
JP5837616B2 (ja) 2015-12-24
IL227281A (en) 2015-06-30
HUE028471T2 (en) 2016-12-28
ECSP13012735A (es) 2013-09-30
TN2013000274A1 (fr) 2014-11-10
TWI438180B (zh) 2014-05-21
UY33845A (es) 2012-07-31
SA112330134B1 (ar) 2014-08-25
MX2013007837A (es) 2013-09-06
TW201309623A (zh) 2013-03-01
RU2550812C2 (ru) 2015-05-20
HRP20160713T1 (hr) 2016-07-29
KR20130115345A (ko) 2013-10-21
CY1117774T1 (el) 2017-05-17
RS54753B9 (sr) 2019-09-30
KR101543432B1 (ko) 2015-08-10
WO2012113999A1 (fr) 2012-08-30
FR2970000A1 (fr) 2012-07-06

Similar Documents

Publication Publication Date Title
CO6852084A2 (es) Nuevos compuestos sustituidos con halógeno
MX2015000082A (es) Fabricacion de acido 2- (5-bromo-4- (4-ciclopropilnaftalen-1-il) -4h-1,2,4-triazol-3-iltio) acetico.
BR112013002925A2 (pt) processo para a síntese de ácido 2,5-furandicarboxílico
EA201300388A1 (ru) Соединения замещенного бензамида
NI200900151A (es) Nuevo procedimiento de síntesis de la agomelatina.
AP2014007436A0 (en) A novel 1,2,3,4,-Tetrahydroquinoline derivative useful for the treatment of diabetes
CL2014002928A1 (es) Proceso para la producción de compuestos químicos a partir de dióxido de carbono
CY1116974T1 (el) Παραγωγα 5-υδροξυπυριμιδινο-4-καρβοξαμιδιου
FR2994432B1 (fr) Procede d'obtention d'une composition riche en luteine produite par des microalgues
BR112012022985A2 (pt) catalisador heterogêneo quiral por reação de nitroaldol assimétrica.
CL2012003371A1 (es) Compuestos intermediarios de la síntesis de agomelatina; y el procedimiento de obtención de agomelatina a partir de dichos compuestos intermediarios
WO2014087208A3 (en) A process of preparing alcaftadine
CL2013001882A1 (es) Procedimiento de sintesis industrial del compuesto de formula (i) agomelatina, a partir de cianuro de alilo; compuestos intermediarios.
UA106195C2 (ru) Способ синтеза агомелатина
MY191759A (en) Processes for the preparation of pyrimidinylcyclopentane compounds
MX2016007186A (es) Nuevo procedimiento de sintesis de la agomelatina.
WO2013190357A8 (en) A process for the preparation of gabapentin
WO2014173917A8 (en) Synthesis of bace inhibitors
BR112014018492A8 (pt) Processo aperfeiçoado para a produção de etileno 1,1-disubstituído
FR2950882B1 (fr) Procede de synthese du 3,5-dichloroanisole a partir du 1,3,5-trichlorobenzene
WO2014061036A3 (en) Tetraoxa diphosphaspiro compounds
WO2011151442A3 (en) Process for producing aliskiren
CL2013001881A1 (es) Procedimiento de sintesis industrial del compuesto agomelatina; compuestos intermediarios.
WO2013054273A3 (en) Process for the preparation of agomelatine
TH58499B (th) กรรมวิธีใหม่สำหรับการสังเคราะห์ของอะโกมีลาทีน